May 21, 2015 / 3:43 PM / in 3 years

BUZZ-U.S. STOCKS ON THE MOVE-Shopify, Lumber Liquidators, IntelliPharmaCeutics

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stocks moved higher in morning trading on Thursday as investors shrugged off fresh batch of weaker-than-expected data, which came a day after the Federal Reserve all but ruled out an interest rate hike in June. The Dow Jones industrial average was up 0.07 percent at 18,298.48 and the S&P 500 was up 0.26 percent at 2,131.35.

** SHOPIFY INC, $25.38, +49.29 pct

Shares of the Canadian e-commerce software maker rose as much as 69 percent in their market debut on the New York Stock Exchange, valuing the company at $2.14 billion.


Lumber Liquidators said Chief Executive Robert Lynch had resigned unexpectedly, even as the company continues to face fire over reports that it sourced flooring laminates with excessive levels of a known carcinogen.

** AMPIO PHARMACEUTICALS INC, $2.49, +22.66 pct

The drug developer says its experimental eye drug was found effective in improving vision in patients with diabetic macular edema, in a mid-stage study.

** KIRKLAND’S INC, $27.8, +10.58 pct

The home decor retailer reports better-than-expected first quarter sales and profit, helped by a 3 percent rise in same-store sales and strong merchandise margins. Kirkland also plans to pay a special cash dividend of $1.50 per share.

** 500.COM LTD, $21.39, -9.25 pct

Deutsche Bank cuts rating on the Chinese online lottery company’s stock to “sell” from “hold”, according to

** EXTREME NETWORKS INC, $2.65, +3.52 pct

The network equipment maker says it will cut about 285 positions, or 18 pct of its global workforce, including contractors. Extreme Networks says it expects to complete job cuts by Sept. 30 and incur $13 million-$15 million in restructuring charges in the current quarter.


The Canadian drugmaker says the U.S. FDA does not need it to conduct late-stage of its abuse-deterrent opioid painkiller if it can demonstrate bioequivalence between the drug, Rexista Oxycodone XR, and the commonly used painkiller Oxycontin.

** STRATASYS LTD, $37.63, +7.61 pct

Oppenheimer upgrades the 3D printer maker’s stock to “outperform”, according to

** FATE THERAPEUTICS INC, $5.77, -6.03 pct

The drug developer says an offering of 6 million shares was priced at $5 per share. The offer price represents a discount of 18.5 percent to the stock’s Wednesday close. Fate says it expects proceeds of about $27.7 million after deductions which it plans to use for clinical development and research, working capital and other general corporate purposes.

** SWIFT ENERGY CO, $2.35, +6.33 pct


** OASIS PETROLEUM INC, $16.935, +5.84 pct

** SEADRILL LTD, $13.72, +7.19 pct

U.S.-listed shares of oil and gas companies rise after oil prices increase, supported by fighting in Iraq and expectations that global supply glut is starting to ease. Brent crude up 1.4 percent at $65.94 per barrel at 10:00 a.m. ET; U.S. crude up 2.1 percent at $60.22.

** SHAKE SHACK INC, $89.5, +8.03 pct

The hamburger chain operator’s unit SSE IP filed an application on April 20 to trademark “Chicken Shack” for chicken sandwiches, according to a filing.

** PRESS GANEY HOLDINGS INC, $28.03, +12.12 pct

Shares of the provider of patient satisfaction surveys to healthcare forms rise as much as 13.7 percent to $28.43 in their debut. Press Ganey was valued at about $1.48 billion at that price.

** OPEN TEXT CORP, $42.98, -12.29 pct

The Canadian business software maker’s shares down after at least nine brokerages cut price targets by as much as $11 to as low as $43. The company forecast fourth-quarter earnings below analysts’ estimate on Wednesday, citing strong dollar.

** DICERNA PHARMACEUTICALS INC, $16.795, -10.14 pct

The drug developer says an offering of 2.7 million shares were priced at $17.75 per share. The offer price represents a discount of 5 percent to the stock’s Wednesday close.

** CALITHERA BIOSCIENCES INC, $12.41, +14.38 pct

The biotech company says lead drug, CB-839, shows promise in patients with acute leukemia in early-stage study. Calithera reported smaller-than-expected first quarter loss this month.

** BEST BUY CO INC, $35.53, +5.18 pct

The largest U.S. consumer electronics chain reported better-than-expected quarterly profit and sales, helped by strong demand for large-screen TVs, smartphones and appliances.

** CVS HEALTH CORP, $104.36, +3.05 pct

** OMNICARE INC, Wednesday close $94.63, +1.76 pct premarket

CVS, the second-largest U.S. drugstore operator, said on Thursday it will buy pharmacy services provider Omnicare for $10.1 billion to expand in the market serving the elderly.

** TRINA SOLAR LTD, $12.29, +11.12 pct

The Chinese solar panel maker reports better-than-expected Q1 revenue, helped by an 84 percent rise in total solar module shipments. Revenue rises 25.5 percent to $558.1 million, above the average analyst estimate of $509.3 million.

** YOUKU TUDOU INC, $25.2, +9.47 pct

China’s biggest online video company’s shares up after Brean Capital raises price target on the stock to $26 from $20. “We are positive on the growth momentum of the company as YOKU continues to transform its business model,” Brean analysts write in a note.

** NETAPP INC, $31.185, -11.73 pct

The data storage equipment maker reported fourth-quarter results below analysts’ estimates, hurt by lower sales to original equipment manufacturers, sending its shares down more than 10 percent in extended trading.

** SALESFORCE.COM INC, $73.32, +4.50 pct

The cloud software company, the subject of takeover speculation for the past few weeks, raised its revenue forecast for the full year after it reported a profit for the first time in seven quarters.

** T-MOBILE US INC, $36.36, +3.27 pct

Deutsche Telekom will consider any partner that can improve profitability at its U.S. operations, its chief executive told the company’s annual shareholders meeting. Chief Executive Tim Hoettges said on Thursday T-Mobile US, of which Deutsche Telekom owns 66 percent, was in much better shape than two years ago. (Compiled by Kshitiz Goliya in Bengaluru; Edited by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below